FDA New, GMP Do
Clinical Phase II, III Intermediates
GMP Custom synthesis, Full Document
R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
This is my R&D youtube: https://youtu.be/r5cJdXKNXHk
| LY-2881835, 1292290-38-0, LY-2881835 Intermediate 137730-67-7, stock 642.1g, white powder, assay by HPLC 99.1%, HNMR, LCMS we supply. |
| LY-2881835, 1292290-38-0, LY-2881835 Intermediate 2417-72-3, stock 376.7g, white powder, assay by HPLC 99.3%, HNMR, LCMS we supply. |
| LY-2881835, 1292290-38-0, LY-2881835 Intermediate 2044283-69-2, stock 243.5g, white powder, assay by HPLC 99%, HNMR, LCMS we supply. |
| LY-2881835, 1292290-38-0, LY-2881835 Intermediate 1292291-10-1, stock 569.3g, white powder, assay by HPLC 98.9%, HNMR, LCMS we supply. |
| LY-2881835, 1292290-38-0, LY-2881835 Intermediate 1292290-97-1, stock 117.7g, white powder, assay by HPLC 98.2%, HNMR, LCMS we supply. |
| LY-2881835, 1292290-38-0, LY-2881835 Intermediate 1292291-39-4, stock 172.2g, white powder, assay by HPLC 99.5%, HNMR, LCMS we supply. |
| LY-2881835, 1292290-38-0, LY-2881835 Intermediate 1292290-38-0, stock 535.2g, white powder, assay by HPLC 99.1%, HNMR, LCMS we supply. |
